Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03490968 · ClinicalTrials.gov registry record · NA
The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03490968 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT03490968, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Test the theory that abnormalities in the large blood vessels that deliver blood to your leg and the very small blood vessels in your leg's muscles (invisible to the eye) work together to worsen your leg function and walking.
Interventions
- BEHAVIORAL Supervised Exercise
- BEHAVIORAL Vascular Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-05-22 |
| Est. Completion | 2023-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03490968
The ClinicalTrials.gov registry entry for NCT03490968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supervised Exercise is the first listed.
NCT03490968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03490968 about?
NCT03490968 is a clinical study titled "The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD". Test the theory that abnormalities in the large blood vessels that deliver blood to your leg and the very small blood vessels in your leg's muscles (invisible to the eye) work together to worsen your leg function and walking.
What is the current status of trial NCT03490968?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-05-22. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT03490968?
The interventions under investigation include: Supervised Exercise (BEHAVIORAL), Vascular Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03490968?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.